Dr. Yu’s research mainly focuses on the discovery of important biomarkers and causal mechanisms underlying complex human diseases by integrating information from multi-omics sources (genomics, epigenomics, and transcriptomics, etc. She’s currently working on proteomics study of bone biopsy, study of pleiotropy and causal risks of inflammatory cytokines to common diseases, and COVID-19 related chemical genetics. Dr. Yu received her PhD training in Biostatistics from Tulane School of Public Health, where she focused on computational epigenomics for osteoporosis.